38,054 Shares in Ventas, Inc. $VTR Acquired by one8zero8 LLC

one8zero8 LLC acquired a new stake in shares of Ventas, Inc. (NYSE:VTR) during the 2nd quarter, Holdings Channel reports. The fund acquired 38,054 shares of the real estate investment trust’s stock, valued at approximately $3,379,000.

A number of other large investors also recently modified their holdings of the company. Dynamic Wealth Strategies LLC bought a new position in Ventas in the 1st quarter worth approximately $25,000. Wiser Advisor Group LLC bought a new stake in shares of Ventas during the third quarter valued at approximately $27,000. Meeder Asset Management Inc. purchased a new position in shares of Ventas in the second quarter worth $30,000. IFC & Insurance Marketing Inc. purchased a new position in shares of Ventas in the fourth quarter worth $30,000. Finally, Elyxium Wealth LLC bought a new position in shares of Ventas during the fourth quarter worth $33,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Insider Activity at Ventas

In other Ventas news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.53% of the company’s stock.

Ventas Trading Up 0.7%

Shares of NYSE VTR opened at $91.81 on Thursday. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The company has a market cap of $47.09 billion, a price-to-earnings ratio of 170.02, a PEG ratio of 2.10 and a beta of 0.69. The business’s 50 day moving average price is $91.00 and its 200-day moving average price is $86.93.

Ventas (NYSE:VTR) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping the consensus estimate of $0.96 by $0.01. The company had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm’s revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.87 EPS. On average, sell-side analysts expect that Ventas, Inc. will post 3.89 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on VTR shares. Wells Fargo & Company lifted their target price on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Evercore reissued an “outperform” rating and set a $95.00 price target on shares of Ventas in a research note on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $100.00 price target on shares of Ventas in a report on Tuesday, June 16th. Citigroup lifted their price objective on Ventas from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Tuesday, August 4th. Finally, Cantor Fitzgerald upped their price objective on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.